A Review of the Integrative Treatment Approach Using the Intravenous Alpha-Lipoic Acid/Low Dose Naltrexone (ALA/N) Protocol for Cancer and a Description of the Long-Term Survival of a Woman with Hepatocellular Carcinoma

A Review of the Integrative Treatment Approach Using the Intravenous Alpha-Lipoic Acid/Low Dose Naltrexone (ALA/N) Protocol for Cancer and a Description of the Long-Term Survival of a Woman with Hepatocellular Carcinoma

This article was originally published in Clinical Oncology. 2021;6:1785. Abstract In this paper we describe the treatment of a 71-year-old female registered nurse (JA) diagnosed with Hepatocellular Carcinoma (HCC) in early October 2006. The patient was a heavy smoker...

Pin It on Pinterest